Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,578.82
(
0.20%
)
US TECH 100
29,489.20
(
0.22%
)
Dow Jones
50,991.61
(
0.64%
)
Brent Oil
91.31
(
-0.94%
)
Bitcoin
73,510.02
(
-0.05%
)
News Focus
News Focus
Post# of 257657
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123037
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 60861

Tuesday, 04/01/2008 9:36:24 AM

Tuesday, April 01, 2008 9:36:24 AM

Post# of 257657
>…the former [Tyzeka] is widely perceived to be an inferior agent in the marketplace…<

Quite so; however, Recothrom is widely perceived to solve a problem that surgeons didn’t even know they had.

>baraclude had pathetic us sales at launch (7M in its first 6 months!)<

The way things appear to be going, you may need some luck to get to $7M of Recothrom sales in the same period.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today